These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 9713427)

  • 21. Angiotensin converting enzyme inhibitors and restenosis: let's stop teasing ourselves.
    Mancini GB
    Cardiovasc Drugs Ther; 2001 Jul; 15(4):293-5. PubMed ID: 11800410
    [No Abstract]   [Full Text] [Related]  

  • 22. Angiotensin-converting enzyme inhibitors, calcium blockers, estrogen and antioxidants in secondary prevention of coronary disease.
    Vogel R
    Can J Cardiol; 1998 Jul; 14 Suppl D():8D-10D. PubMed ID: 9713419
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Acute effects of ACE inhibition on coronary endothelial dysfunction.
    Nickenig G; Stäblein A; Wassmann S; Wyen C; Müller C; Böhm M
    J Renin Angiotensin Aldosterone Syst; 2000 Dec; 1(4):361-4. PubMed ID: 11967824
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Vascular wall renin-angiotensin system as a target of therapeutic interventions].
    Karpov IuA
    Kardiologiia; 2003; 43(5):82-6. PubMed ID: 12942932
    [No Abstract]   [Full Text] [Related]  

  • 25. Medical treatment of chronic valvular regurgitation.
    Schön HR
    J Heart Valve Dis; 1995 Oct; 4 Suppl 2():S170-4. PubMed ID: 8563994
    [No Abstract]   [Full Text] [Related]  

  • 26. [Angiotensin converting enzyme-angiotensin II system, atherosclerosis, and angiotensin-converting enzyme inhibitors].
    Aronov DM
    Ter Arkh; 2000; 72(12):5-7. PubMed ID: 11201833
    [No Abstract]   [Full Text] [Related]  

  • 27. [Effects of ACE inhibitors on angiographic restenosis after coronary stenting (PARIS): double-blind randomized trial].
    Gnecchi M; Ardissino D
    Ital Heart J Suppl; 2001 Sep; 2(9):1027-8. PubMed ID: 11675825
    [No Abstract]   [Full Text] [Related]  

  • 28. Current trials on angiotensin-converting enzyme inhibitors and endothelial dysfunction.
    Anderson T
    Can J Cardiol; 1998 Jul; 14 Suppl D():33D-34D. PubMed ID: 9713430
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The Quinapril Ischemic Event Trial (QUIET).
    Pitt B
    Blood Press Suppl; 1992; 4():11-2. PubMed ID: 1345328
    [No Abstract]   [Full Text] [Related]  

  • 30. The role of the renin-angiotensin system in vascular health: use of ACE inhibition to improve vascular function.
    Izzo JL
    Heart Dis; 2000; 2(5):380-3. PubMed ID: 11728286
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Should angiotensin-converting enzyme-inhibitors be used to improve outcome in patients with coronary artery disease and 'preserved' left ventricular function?
    Fox K; Ferrari R; Yusuf S; Borer JS
    Eur Heart J; 2006 Sep; 27(18):2154-7. PubMed ID: 16905555
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical restenosis trials: a perspective from the pharmaceutical industry.
    Uprichard AC; Texter M; Canter D
    Circulation; 1992 Apr; 85(4):1636-7. PubMed ID: 1555305
    [No Abstract]   [Full Text] [Related]  

  • 33. Endothelial dysfunction: its pathogenic role in atherosclerosis and its reversal by ACE inhibition.
    Neutel JM
    Postgrad Med; 2000 Oct; 108(5 Suppl):4-11. PubMed ID: 19667535
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Circulating intercellular cell adhesion molecule-1, endothelin-1 and von Willebrand factor-markers of endothelial dysfunction in uncomplicated essential hypertension: the effect of treatment with ACE inhibitors.
    Hlubocká Z; Umnerová V; Heller S; Peleska J; Jindra A; Jáchymová M; Kvasnicka J; Horký K; Aschermann M
    J Hum Hypertens; 2002 Aug; 16(8):557-62. PubMed ID: 12149661
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Endothelial function and atherosclerosis.
    Biegelsen ES; Loscalzo J
    Coron Artery Dis; 1999 Jun; 10(4):241-56. PubMed ID: 10376203
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of angiotensin-converting enzyme inhibition in low-risk patients early after coronary artery bypass surgery.
    Rouleau JL; Warnica WJ; Baillot R; Block PJ; Chocron S; Johnstone D; Myers MG; Calciu CD; Dalle-Ave S; Martineau P; Mormont C; van Gilst WH;
    Circulation; 2008 Jan; 117(1):24-31. PubMed ID: 18071079
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Renin-angiotensin system and atherothrombotic disease: from genes to treatment.
    Jacoby DS; Rader DJ
    Arch Intern Med; 2003 May; 163(10):1155-64. PubMed ID: 12767951
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Comparative study of the effect of ACE-inhibition, angiotensin II antagonism, and calcium channel blockade on flow-mediated vasodilation in patients with coronary disease (BANFF study].
    Eleuteri E
    Ital Heart J Suppl; 2000 Jun; 1(6):830-1. PubMed ID: 11204017
    [No Abstract]   [Full Text] [Related]  

  • 39. Effect of angiotensin-converting enzyme inhibitor therapy in mitral regurgitation with normal left ventricular function.
    Ray JG
    Can J Cardiol; 1997 Aug; 13(8):780-1, 783. PubMed ID: 9284846
    [No Abstract]   [Full Text] [Related]  

  • 40. Quinapril--a new angiotensin-converting enzyme inhibitor: an overview.
    Dzau VI
    Angiology; 1989 Apr; 40(4 Pt 2):329-30. PubMed ID: 2705641
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.